Goldman Sachs’s Epizyme, Inc EPZM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $3.87M | Sell |
|
|||||
|
2022
Q1 | $6.6M | Buy |
|
|||||
|
2021
Q4 | $8.16M | Buy |
|
|||||
|
2021
Q3 | $2.93M | Buy |
|
|||||
|
2021
Q2 | $4.59M | Sell |
|
|||||
|
2021
Q1 | $6.2M | Buy |
|
|||||
|
2020
Q4 | $6.8M | Buy |
|
|||||
|
2020
Q3 | $6.57M | Sell |
|
|||||
|
2020
Q2 | $10.1M | Buy |
|
|||||
|
2020
Q1 | $6.84M | Sell |
|
|||||
|
2019
Q4 | $11.9M | Sell |
|
|||||
|
2019
Q3 | $5.71M | Buy |
|
|||||
|
2019
Q2 | $5.9M | Buy |
|
|||||
|
2019
Q1 | $5.1M | Buy |
|
|||||
|
2018
Q4 | $1.02M | Buy |
|
|||||
|
2018
Q3 | $1.47M | Buy |
|
|||||
|
2018
Q2 | $1.54M | Sell |
|
|||||
|
2018
Q1 | $2.17M | Sell |
|
|||||
|
2017
Q4 | $1.66M | Sell |
|
|||||
|
2017
Q3 | $4.3M | Buy |
|
|||||
|
2017
Q2 | $1.53M | Buy |
|
|||||
|
2017
Q1 | $839K | Sell |
|
|||||
|
2016
Q4 | $646K | Buy |
|
|||||
|
2016
Q3 | $229K | Buy |
|
|||||
|
2016
Q2 | $165K | Buy |
|
|||||
|
2016
Q1 | $184K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $1.05M | Sell |
|
|||||
|
2015
Q2 | $5.03M | Buy |
|
|||||
|
2015
Q1 | $218K | Sell |
|
|||||
|
2014
Q4 | $521K | Buy |
|
|||||
|
2014
Q3 | $332K | Buy |
|
|||||
|
2014
Q2 | $223K | Buy |
|